Olema Pharmaceuticals: Peers

The FY2025 (Dec) proxy of Olema Pharmaceuticals names 28 peer companies for pay. Among Olema Pharmaceuticals and these peers, CEO pay was 13th highest of 15 and total shareholder return was the highest of 15.

13th highest of 15in Olema Pharmaceuticals and its pay peers, FY2025 (Dec) by CEO pay:

$2.3M$27.8M

1st highest of 15in Olema Pharmaceuticals and its pay peers, FY2025 (Dec) by total shareholder return:

$14$1,020

Pay peer group, FY2025 (Dec) proxy

Cogent Biosciences
Arcus Biosciences
Praxis Precision Medicines
MeiraGTx Holdings
Vir Biotechnology
Arvinas
Anaptysbio
Oric Pharmaceuticals
Cullinan Therapeutics
Kura Oncology
Relay Therapeutics
Annexon
Keros Therapeutics
Verastem
AlectorNot disclosedNot disclosed
AlumisNot disclosedNot disclosed
Amylyx Pharmaceuticals (amlx)Not disclosedNot disclosed
Arcturus Therapeutics HoldingsNot disclosedNot disclosed
Aura BiosciencesNot disclosedNot disclosed
ErascaNot disclosedNot disclosed
Inhibrx BiosciencesNot disclosedNot disclosed
KalVista PharmaceuticalsNot disclosedNot disclosed
Kodiak SciencesNot disclosedNot disclosed
Nuvation BioNot disclosedNot disclosed
Syndax PharmaceuticalsNot disclosedNot disclosed
Terns PharmaceuticalsNot disclosedNot disclosed
XencorNot disclosedNot disclosed
Zenas BioPharmaNot disclosedNot disclosed
28 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.